Status
Conditions
Treatments
About
This open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study was performed in order to examine the efficacy and safety of Somavert® in treatment of subjects with acromegaly and its effects on acromegaly related co-morbidities.
Full description
Non probability samples
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
311 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal